Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Simulations Plus Inc
(NQ:
SLP
)
32.05
-0.45 (-1.38%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Simulations Plus Inc
< Previous
1
2
3
4
Next >
Simulations Plus 25th Anniversary Celebration Concludes with $25,000 Gift to Nonprofit, Girls Who Code
November 03, 2022
From
Simulations Plus
Via
Business Wire
Simulations Plus and the University of Florida Awarded New FDA Contract to Support Development and Regulatory Assessment of Inhaled Products
November 02, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Reports Fourth Quarter and Full Fiscal Year 2022 Financial Results
October 26, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Announces Cash Dividend
October 20, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Releases GastroPlus® Version 9.8.3
October 12, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Sets Date for Fourth Quarter and Fiscal Year 2022 Earnings Release and Conference Call
October 11, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus to Present at Sidoti Fall Small Cap Investor Conference
September 14, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus to Present at Baird 2022 Global Healthcare Conference
September 07, 2022
From
Simulations Plus
Via
Business Wire
Simulations Plus Releases State-of-the-Art QSP Software for Interstitial Lung Disease
August 31, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Enters New Collaboration to Enhance Machine Learning Models for Ionization Constants (pKa)
August 04, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Presented New Scientific Developments at PAGE 2022
July 26, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit International Organization for Childhood Cancer
July 21, 2022
From
Simulations Plus
Via
Business Wire
Simulations Plus Realizes Early Success with its Concierge Program
July 14, 2022
From
Simulations Plus, Inc
Via
Business Wire
Simulations Plus Reports Third Quarter Fiscal 2022 Financial Results
July 06, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Hosts 2nd Annual Pharmacometrics Workshop
June 30, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Collaborates with Multinational Pharmaceutical Company to Provide Modeling & Simulation Support for COVID-19 Treatment
June 23, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Sets Date for Third Quarter Fiscal Year 2022 Earnings Release and Conference Call
June 21, 2022
From
Simulations Plus, Inc.
Via
Business Wire
DILIsym Software Publication Outlines Impact on the CGRP Field for Migraine
June 16, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Releases ADMET Predictor Version 10.4 (X.4)
May 26, 2022
From
Simulations Plus, Inc.
Via
Business Wire
U.S. FDA Renews Annual DILIsym Software Licenses for 2022
May 05, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Successfully Delivers FDA-Funded Project
April 28, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Enters New Collaboration to Advance DDDPlus™ Software
April 21, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus to Present at the Berenberg Discover AI Seminar
April 19, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Reports Second Quarter Fiscal 2022 Financial Results
April 06, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety Software
March 29, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific Conference
March 24, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Sets Date for Second Quarter Fiscal Year 2022 Earnings Release and Conference Call
March 22, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit National Organization for Rare Disorders
March 17, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 08, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Partners with Large Pharmaceutical Company to Drive Advancements to the GastroPlus Mechanistic Oral Absorption Model
January 20, 2022
From
Simulations Plus, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.